Amgen Inc. raises 2025 revenue guidance on strong Repatha and Imdelltra sales and dividend hike. Click for this AMGN update.
In the expansive world of regenerative medicine and biochemistry, few molecules have generated as much sustained excitement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback